Separate names with a comma.
The idea of “personalized medicine” -- or treatments that are developed and administered on a patient-by-patient basis -- has always been a...
At an AIDS conference in Paris on July 24, 2017, Johnson&Johnson announced updates on its developmental AIDS drug. And guess what, it's good news!